Vertex Pharmaceuticals, Inc. (VRTX)

440.67 +5.02 (+1.15%) USD  |  NASDAQ  |  Apr 17, 15:31
More

Vertex Pharmaceuticals FCF to Assets (TTM)

FCF to Assets (TTM) Chart

View FCF to Assets (TTM) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View FCF to Assets (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

FCF to Assets (TTM) Range, Past 5 Years

View FCF to Assets (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

FCF to Assets (TTM) Benchmarks

View FCF to Assets (TTM) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Eli Lilly & Co. Upgrade
Amgen, Inc. Upgrade
Moderna, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade